Trends in Endocrinology & Metabolism
ReviewNew clues about vitamin D functions in the nervous system
Section snippets
Brain 1,25-(OH)2D3 synthesis and degradation
Vitamin D3 can either be ingested, or synthesized in the skin from 7-dehydrocholesterol during exposure to sunlight in a reaction that is catalyzed by ultraviolet B radiation [1]. In both cases, vitamin D3 is biologically inert and requires a two-step enzymatic activation (Fig. 1). It was assumed that the brain 1,25-(OH)2D3 supply was dependent on the plasma concentration of 1,25-(OH)2D3 2., 3., 4.. However, recent data demonstrating the brain localization of vitamin D3 25-hydroxylase and
The vitamin D receptor (VDR)
The nuclear functions of 1,25-(OH)2D3 are mediated through the vitamin D receptor (VDR) 10., 11.. Since the initial reports of Stumpf and collaborators on the presence of vitamin D-specific nuclear binding in brain and spinal cord 12., 13., 14., evidence has accumulated to suggest that both mRNA encoding the VDR and the protein itself are present in the nervous system. Thus, VDR gene expression has been demonstrated in neuronal and glial cells 15., 16., 17., 18., 19., 20., 21., 22., 23.. VDR
Neuroprotective effects of 1,25-(OH)2D3
Since the regulation of nerve growth factor (NGF) synthesis by 1,25-(OH)2D3 was first reported [36], various studies have demonstrated that 1,25-(OH)2D3 can act on cells of the nervous system by modulating the production of neurotrophins (Fig. 2; Table 1). For instance, the synthesis of NGF 17., 20., 37., neurotrophin 3 (NT3) [38] and glial cell line-derived neurotrophic factor (GDNF) [39] was upregulated by 1,25-(OH)2D3, whereas neurotrophin 4 (NT4) was downregulated [38]. In several cases,
CNS tumors
The potential role of vitamin D in the treatment of cancer was first recognized in 1981 in myeloid leukemic cells [57]. It was then extended to several other malignancies, including breast, prostate and colon carcinoma. These antiproliferative properties have led to the development of numerous pharmacological analogs that inhibit cancer cell growth with reduced calcemic activity. In CNS tumors, 1,25-(OH)2D3 and several synthetic analogs are effective in inducing a cell death pathway in glioma
Concluding remarks
Currently available data strongly suggest a role for 1,25-(OH)2D3 in the nervous system. However, patients suffering from rickets show no obvious nervous dysfunction. In the same way, no gross abnormalities were identified in the brain of VDR- or 25-hydroxyvitamin D 1α-hydroxylase-deficient mice 74., 75., 76.. Even though the nervous systems of these knockout mice require more detailed study, this suggests that 1,25-(OH)2D3 functions might overlap with other signaling pathways. For instance, it
Acknowledgements
We are grateful to A. Goldsmith for helpful comments on the article. This review is dedicated to INSERM U298 (1986–1998).
References (81)
Porcine microsomal vitamin D3 25-hydroxylase (CYP2D25)
J. Biol. Chem.
(2000)1,25-Dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells
Mol. Brain Res.
(1994)1,25-Dihydroxyvitamin D3 receptors in developing dorsal root ganglia of fetal rats
Dev. Brain Res.
(1996)1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo
Brain Res.
(1998)Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord
J. Chem. Neuroanat.
(1999)Evidence of functional vitamin D receptors in rat hippocampus
Neuroscience
(2001)RXR-β: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response element
Cell
(1991)Vitamin D receptor and nuclear receptor coactivators: crucial interactions in vitamin D-mediated transcription
Steroids
(2001)Rapid, nongenomic steroid actions: a new age?
Front. Neuroendocrinol.
(2000)Membrane receptors for steroid hormones: a case for specific cell surface binding sites for vitamin D metabolites and estrogens
Biochem. Biophys. Res. Commun.
(1998)